Early detection of ovarian cancer using uterine lavage and duplex sequencing
Ended Project Grant Awarded Last action
- Award ID
- R44CA221426
- Recipient
-
Twinstrand Biosciences Inc. UEI HPY9BJWV8X31
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,258,850
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Originally
- Place of performance
- Washington, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$0 | |
| Amendment | -$0 | |
| Amendment | -$12,186 | |
| Amendment | -$12,186 | |
| Amendment | -$12,186 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $221,887 | |
| Amendment | $134,960 | |
| Amendment | $819,300 | |
| Amendment | $823,853 | |
| Amendment | $0 | |
| Original award | $295,409 |
Show all 13
Quick answers
Who received award R44CA221426?
R44CA221426 was awarded to Twinstrand Biosciences Inc. by National Cancer Institute (National Institutes of Health) on September 1, 2017.
How much is award R44CA221426 worth?
$2,258,850 has been obligated on R44CA221426.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award